United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read Energy Industry News ClearVue (ASX: CPV) just raised A$4.6m—what’s driving investor interest in its solar glass tech? ClearVue Technologies raises A$4.6M to certify Gen3 solar glass, expand BIPV adoption, and drive commercial growth across global façade markets. Read the full update. bySrinathOctober 13, 2025